Prime Medicine, Inc. (PRME)
NASDAQ·Healthcare·Biotechnology
$3.05
-1.62%
Mkt Cap $536.43M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
Implied Upside
+466.5%
Consensus $17.25 vs current $3.05
NASDAQ·Healthcare·Biotechnology
$3.05
-1.62%
Mkt Cap $536.43M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
+466.5%
Consensus $17.25 vs current $3.05